Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial

Background: Despite recent advances in mobilization techniques, a considerable portion of patients fail to mobilize sufficient number of cells for successful autologous stem cell transplantation. There are several studies available that have demonstrated enhanced mobilization of endothelial progenit...

Full description

Bibliographic Details
Main Authors: Mehdi Mohammadi, Mohammad Vaezi, Bahram Chahardouli, Molouk Hadjibabaie, Ardeshir Ghavamzadeh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2016-02-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/468
_version_ 1797760795840348160
author Mehdi Mohammadi
Mohammad Vaezi
Bahram Chahardouli
Molouk Hadjibabaie
Ardeshir Ghavamzadeh
author_facet Mehdi Mohammadi
Mohammad Vaezi
Bahram Chahardouli
Molouk Hadjibabaie
Ardeshir Ghavamzadeh
author_sort Mehdi Mohammadi
collection DOAJ
description Background: Despite recent advances in mobilization techniques, a considerable portion of patients fail to mobilize sufficient number of cells for successful autologous stem cell transplantation. There are several studies available that have demonstrated enhanced mobilization of endothelial progenitor cells with atorvastatin. Therefore, this prospective trial was conducted to evaluate the mobilizing effect of atorvastatin on hematopoietic progenitor cells. Subjects and Methods: Forty-four autologous HSCT candidates were randomized in a double-blind controlled trial to receive atorvastatin 40 mg daily or placebo plus standard G-CSF regimen. Treatment was initiated at the time of hospitalization and continued until the day of cell harvest. Independent-samples T-Test, Repeated Measures ANOVA and Mann-Whitney U test were performed to compare means. Categorical variables were analyzed using Chi-square and Fisher’s exact test. Results: Mean number of hematopoietic progenitor cells per microL of peripheral blood at the time of cell harvest did not differ significantly between the two groups. There was no statistically significant difference in secondary outcomes like time of platelet or PMN engraftment, occurrence of bleeding or infectious episode, duration of hospitalization and etc. Conclusion: The results of this study did not support beneficial effects of atorvastatin on mobilization of hematopoietic progenitor cells from bone marrow.
first_indexed 2024-03-12T19:04:39Z
format Article
id doaj.art-d5c388ef242d4c74a85f567c741b1901
institution Directory Open Access Journal
issn 2008-2207
language English
last_indexed 2024-03-12T19:04:39Z
publishDate 2016-02-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-d5c388ef242d4c74a85f567c741b19012023-08-02T06:24:43ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072016-02-0194456Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trialMehdi Mohammadi0Mohammad Vaezi1Bahram Chahardouli2Molouk Hadjibabaie3Ardeshir Ghavamzadeh4Clinical Pharmacy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranResearch Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran. AND Clinical Pharmacy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranBackground: Despite recent advances in mobilization techniques, a considerable portion of patients fail to mobilize sufficient number of cells for successful autologous stem cell transplantation. There are several studies available that have demonstrated enhanced mobilization of endothelial progenitor cells with atorvastatin. Therefore, this prospective trial was conducted to evaluate the mobilizing effect of atorvastatin on hematopoietic progenitor cells. Subjects and Methods: Forty-four autologous HSCT candidates were randomized in a double-blind controlled trial to receive atorvastatin 40 mg daily or placebo plus standard G-CSF regimen. Treatment was initiated at the time of hospitalization and continued until the day of cell harvest. Independent-samples T-Test, Repeated Measures ANOVA and Mann-Whitney U test were performed to compare means. Categorical variables were analyzed using Chi-square and Fisher’s exact test. Results: Mean number of hematopoietic progenitor cells per microL of peripheral blood at the time of cell harvest did not differ significantly between the two groups. There was no statistically significant difference in secondary outcomes like time of platelet or PMN engraftment, occurrence of bleeding or infectious episode, duration of hospitalization and etc. Conclusion: The results of this study did not support beneficial effects of atorvastatin on mobilization of hematopoietic progenitor cells from bone marrow.https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/468AtorvastatinAutologousHSCTMobilization
spellingShingle Mehdi Mohammadi
Mohammad Vaezi
Bahram Chahardouli
Molouk Hadjibabaie
Ardeshir Ghavamzadeh
Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
International Journal of Hematology-Oncology and Stem Cell Research
Atorvastatin
Autologous
HSCT
Mobilization
title Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
title_full Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
title_fullStr Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
title_full_unstemmed Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
title_short Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial
title_sort effects of short term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells a double blind randomized controlled trial
topic Atorvastatin
Autologous
HSCT
Mobilization
url https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/468
work_keys_str_mv AT mehdimohammadi effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial
AT mohammadvaezi effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial
AT bahramchahardouli effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial
AT moloukhadjibabaie effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial
AT ardeshirghavamzadeh effectsofshorttermpretreatmentwithatorvastatinonmobilizationofhematopoieticprogenitorcellsadoubleblindrandomizedcontrolledtrial